Westlaw Edge login and Westlaw Edge sign in: pricing, free trial and what changed

Most of what is written about Westlaw Edge was published before Precision and Advantage existed, and it describes a product line with two tiers instead of four names. So we did the boring thing: plain HTTP requests to every Westlaw address a lawyer might have in a bookmark, plus the marketing pages for each product name. The status codes explain almost all of the confused searching around this product.

All rows read directly from edge.westlaw.com, www.westlaw.com, 1.next.westlaw.com, legal.thomsonreuters.com and sales.legalsolutions.thomsonreuters.com on 24 August 2026. Vendor infrastructure changes without notice, so re-check before relying on any of it.

One row deserves more than a table cell. The 404 on a URL that never existed is what makes the rest of the table meaningful. If Thomson Reuters had put a blanket rule at the edge sending every unknown path somewhere sensible, the redirects on the Precision and Classic pages would tell you nothing, because everything would redirect. It does not. An invented path gets a normal 404, so each 301 above is a deliberate decision about a specific product name. Somebody at Thomson Reuters sat down and decided that Classic points at Edge and Precision points at Advantage. That is a roadmap, published accidentally in HTTP headers.

Taken from the Thomson Reuters Westlaw Edge page on 24 August 2026. The 2018 launch feature set and the 2024 AI additions are now described together under one heading, which is why feature lists written a few years apart disagree so badly.

Two absences are worth naming, because they decide purchases. Deep Research, the agentic multi-step research feature, is an Advantage feature and not an Edge one. And CoCounsel is not part of Edge at all: the Edge page links out to CoCounsel Legal and CoCounsel Essentials as separate products, which means a firm that wants Westlaw research and CoCounsel drafting is signing two agreements, not upgrading one.

One small thing we noticed while reading the page, offered as an observation rather than an accusation: the sentence claiming Westlaw is the most trusted and award-winning legal research service is peppered with zero-width characters between the letters, so it does not match a plain text search for the phrase. Harvey does the same thing to the statistics on its homepage. It is a common enough trick on vendor sites that anyone quoting a marketing claim should copy it out of the rendered page rather than the source.

This is the most searched question about the product and the answer is genuinely awkward, so we split every claim into what Thomson Reuters states on its own site and what buyers and reviewers report. The two never get merged into one figure, because merging them is how a guess turns into a fact that gets repeated for a decade.

The useful move here is to use the one published number as leverage. Thomson Reuters has already told the internet that Advantage starts at 256.75 dollars per month for a single circuit. Edge sits below Advantage in the line. So an Edge quote materially above the Advantage floor is worth questioning out loud, and an Edge quote close to it is worth converting into an Advantage conversation, because at that point you are paying middle-tier money for a tier without Deep Research. Ask for both quotes side by side and make the rep write down which features differ.

Watch the scope line too. The gap between 256.75 for one circuit and 399.75 for all states plus federal is 143 dollars a month, and jurisdiction scope is where research subscriptions quietly get expensive. A single-state practice that occasionally needs an out-of-circuit case is the exact profile that ends up paying the all-states rate for a handful of lookups a year. That is worth checking against what the rest of the legal research market charges before you sign a three-year term for the discount.

Three of these are Thomson Reuters tiers of the same product and two are different products entirely. We have put our own tool in the table because leaving it out would be coy, and we have written the row about ourselves the way we would want a rival to write it.

To say the quiet part plainly: if KeyCite Overruling Risk is load-bearing in your practice, keep paying Thomson Reuters. We do not have a citator and nothing on this page is an argument that you should drop one. Where we are a real answer is the firm paying Edge money mostly to look up cases, doing its citator checks in a cheaper way, and wondering why finding the controlling authority costs four figures a year. If that is you, run a question through the box at the top of this page and see how far it gets before you renew.